TITLE
Transriptome analysis of LNCaP/AR cell line after concomittant treatment with androgen with bicalutamide and enzalutamide

ORGANISM
Homo sapiens

SUMMARY
Transriptome analysis of LNCaP/AR cell line after concomittant treatment with androgen with bicalutamide and enzalutamide

DESIGN
LNCaP/AR cells growing in log phase were treated for 24 hours with vehicle, the androgen DHT, and DHT plus either bicalutamide or enzalutamide for 24 hours.

PLATFORM
GPL6947 Illumina HumanHT-12 V3.0 expression beadchip

CITATIONS
Has this study been published? Please login to update or notify GEO .

